Company Filing History:
Years Active: 1998-2002
Title: Cori M Gorman: Innovator in Gene Targeting Technologies
Introduction
Cori M Gorman is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of gene targeting technologies, holding a total of 3 patents. His work focuses on the development of pharmaceutical compositions and methods for the targeted delivery of functional genes into cells and tissues.
Latest Patents
Cori's latest patents include innovative inventions such as "Cationic lipid:DNA complexes for gene targeting." This invention describes pharmaceutical compositions and methods for the targeted delivery of functional genes into cells and tissues in vivo. The invention discloses DNA:lipid complexes, methods of making such complexes, and methods of using such complexes for facilitating the targeted delivery and entry of recombinant expression constructs into cells and tissues in vivo. Notably, it emphasizes the delivery of such recombinant expression constructs by intravenous, intraperitoneal, or direct injection. Another patent with a similar title also focuses on the targeted delivery of functional genes, specifically to lung cells and tissues.
Career Highlights
Throughout his career, Cori has worked with several companies, including Valentis, Inc. and Megabios Corporation. His experience in these organizations has contributed to his expertise in the field of gene therapy and targeted delivery systems.
Collaborations
Cori has collaborated with various professionals in his field, including his coworker, Molly McClarrinon. Their partnership has likely fostered innovative ideas and advancements in their shared area of expertise.
Conclusion
Cori M Gorman's contributions to gene targeting technologies highlight his role as an influential inventor in the field. His patents and career achievements reflect his commitment to advancing pharmaceutical sciences and improving gene delivery methods.